Assessing and grading congestion in acute heart failure: A scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine

European Journal of Heart Failure

Volumn 12, Issue 5, 2010, Pages 423-433

  Gheorghiade, Mihai ^a   Follath, Ferenc ^b   Ponikowski, Piotr ^c   Barsuk, Jeffrey H ^a   Blair, John E A ^d   Cleland, John G ^e   Dickstein, Kenneth ^f,g   Drazner, Mark H ^h   Fonarow, Gregg C ⁱ   Jaarsma, Tiny ^j   Jondeau, Guillaume ^k   Sendon, Jose Lopez ^l   Mebazaa, Alexander ^m,n   Metra, Marco ^o   Nieminen, Markku ^p   Pang, Peter S ^a   Seferovic, Petar ^q   Stevenson, Lynne W ^r   Van Veldhuisen, Dirk J ^s   Zannad, Faiez ^t   Anker, Stefan D ^t   Rhodes, Andrew ^u   McMurray, John J V ^v   Filippatos, Gerasimos ^w   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MILITARY HOSPITAL   (Poland)

^d WILFORD HALL MEDICAL CENTER   (United States)

^e UNIVERSITY OF HULL   (United Kingdom)

^f STAVANGER UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF BERGEN   (Norway)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k BICHAT HOSPITAL   (France)

^l HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^m HÔPITAL LARIBOISIÈRE   (France)

ⁿ INSERM   (France)

^o UNIVERSITY OF BRESCIA   (Italy)

^p HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^q Institute for Cardiovascular Disease   (Serbia)

^r BRIGHAM AND WOMEN S HOSPITAL   (United States)

^s UNIVERSITÉ DE LORRAINE   (France)

^t CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^u ST GEORGE S HOSPITAL   (United Kingdom)

^v UNIVERSITY OF GLASGOW   (United Kingdom)

^w NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

more..

Author keywords

Acute heart failure; Congestion; Risk assessment; Score

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; ROLOFYLLINE; TOLVAPTAN; VASOPRESSIN ANTAGONIST;

ACUTE HEART FAILURE; ADVISORY COMMITTEE; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMEGALY; CARDIOVASCULAR SYSTEM EXAMINATION; CENTRAL VENOUS PRESSURE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DYSPNEA; ECHOCARDIOGRAPHY; EXERCISE; HOSPITAL PATIENT; HUMAN; HYPOKALEMIA; IMPEDANCE CARDIOGRAPHY; INTENSIVE CARE; KIDNEY FUNCTION; LABORATORY DIAGNOSIS; LUNG EDEMA; MEDICAL SOCIETY; MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; PERIPHERAL EDEMA; PLEURA EFFUSION; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STANDING; THORAX RADIOGRAPHY; TISSUE DOPPLER IMAGING; ULTRASOUND; UREA NITROGEN BLOOD LEVEL; VALSALVA MANEUVER; VASOCONSTRICTION; ABNORMAL RESPIRATORY SOUND; ALGORITHM; CARDIOLOGY; CLASSIFICATION; DIZZINESS; EUROPE; HEALTH SURVEY; HEART EDEMA; HEART FAILURE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT;

ALGORITHMS; CARDIOLOGY; DIZZINESS; DYSPNEA; EDEMA, CARDIAC; EUROPE; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; INTENSIVE CARE; PHYSICAL EXERTION; PROGNOSIS; RESPIRATORY SOUNDS; RISK ASSESSMENT; SOCIETIES, MEDICAL;

EID: 77957227912     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq045     Document Type: Article

References (110)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Auricchio A, Bax J, Bohm M, Corra U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
2. Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112:3958-3968. (Pubitemid 43739494)
3. Filippatos G, Zannad F. An introduction to acute heart failure syndromes: definition and classification. Heart Fail Rev 2007;12:87-90. (Pubitemid 46916952)
4. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463. (Pubitemid 36286187)
5. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296:2217-2226. (Pubitemid 44708052)
6. Nunez J, Nunez E, Fonarow GC, Sanchis J, Bodi V, Bertomeu-Gonzalez V, Minana G, Merlos P, Bertomeu-Martinez V, Redon J, Chorro FJ, Llacer A. Differential prognostic effect of systolic blood pressure on mortality according to leftventricular function in patients with acute heart failure. Eur J Heart Fail 12:38-44.
7. Ezekowitz JA, Bakal JA, Kaul P, Westerhout CM, Armstrong PW. Acute heart failure in the emergency department: short-and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail 2008;10:308-314.
8. Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 2008;10:140-148. (Pubitemid 351221390)
9. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216. (Pubitemid 40348525)
10. O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 2005;11:200-205. (Pubitemid 40462423)
11. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 2006;27:1207-1215.
12. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 2006;119 (12 Suppl. 1): S3-S10. (Pubitemid 44755377)
13. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581. (Pubitemid 32772099)
14. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW. Freedom from congestion predicts good survival despite previous class IV symptomsofheart failure. Am Heart J 2000;140:840-847.
15. Bonow RO, Bennett S, Casey DE Jr, Ganiats TG, Hlatky MA, Konstam MA, Lambrew CT, Normand SL, Pina IL, Radford MJ, Smith AL, Stevenson LW, Bonow RO, Bennett SJ, Burke G, Eagle KA, Krumholz HM, Lambrew CT, Linderbaum J, Masoudi FA, Normand SL, Ritchie JL, Rumsfeld JS, Spertus JA. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2005;46:1144-1178. (Pubitemid 41316528)
16. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006;12:10-38.
17. Werner RM, Bradlow ET. Relationship between Medicare's hospital compare performance measures and mortality rates. JAMA 2006;296:2694-2702. (Pubitemid 44920181)
18. Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003;41:565-571. (Pubitemid 36223320)
19. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-848. (Pubitemid 41170070)
20. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549-1554. (Pubitemid 47511418)
21. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008;10:165-169. (Pubitemid 351222743)
22. Milo-Cotter O, Adams KF, O'Connor CM, Uriel N, Kaluski E, Felker GM, Weatherley B, Vered Z, Cotter G. Acute heart failure associated with high admission blood pressure-a distinct vascular disorder? Eur J Heart Fail 2007;9:178-183. (Pubitemid 46394490)
23. Mahdyoon H, Klein R, Eyler W, Lakier JB, Chakko SC, Gheorghiade M. Radiographic pulmonary congestion in end-stage congestive heart failure. Am J Cardiol 1989;63:625-627. (Pubitemid 19070125)
24. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-888. (Pubitemid 19046417)
25. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:355-359.
26. Perna ER, Macin SM, Cimbaro Canella JP, Alvarenga PM, Rios NG, Pantich R, Augier N, Farias EF, Jantus E, Brizuela M, Medina F. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol 2005;99:253-261. (Pubitemid 40320798)
27. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-838. (Pubitemid 37022125)
28. Filippatos G, Tilak M, Pinillos H, Uhal BD. Regulation of apoptosis by angiotensin II in the heart and lungs (Review). Int J Mol Med 2001;7:273-280.
29. Firth JD, Raine AE, Ledingham JG. Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1988;1:1033-1035.
30. Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 2008;51:300-306.
31. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008;51:1268-1274. (Pubitemid 351400890)
32. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-585. (Pubitemid 29384167)
33. Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 2004;291:1963-1971. (Pubitemid 38544277)
34. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797-1804. (Pubitemid 36584255)
35. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005;294:1625-1633. (Pubitemid 41407355)
36. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147-152. (Pubitemid 14085366)
37. Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, Kobashigawa J, Walden J. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990;66:1348-1354.
38. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008;118:1433-1441.
39. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004;147:331-338. (Pubitemid 38176835)
40. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006;47:1-8. (Pubitemid 43005157)
41. Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF Jr. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007;9:1064-1069. (Pubitemid 47451811)
42. Jhund PS, McMurray JJ, Davie AP. The acute vascular effects of frusemide in heart failure. Br J Clin Pharmacol 2000;50:9-13. (Pubitemid 30416964)
43. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 2008;10:188-195. (Pubitemid 351221392)
44. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683. (Pubitemid 46205043)
45. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 2007;297:1332-1343. (Pubitemid 46513234)
46. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007;297:1319-1331. (Pubitemid 46513233)
47. Cleland JG, Coletta AP, Yassin A, Buga L, Torabi A, Clark AL. Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT. Eur J Heart Fail 2009;11:1214-1219.
48. De Luca L, Mebazaa A, Filippatos G, Parissis JT, Bohm M, Voors AA, Nieminen M, Zannad F, Rhodes A, El-Banayosy A, Dickstein K, Gheorghiade M. Overview of emerging pharmacologic agents for acute heart failure syndromes. Eur J Heart Fail 2008;10:201-213. (Pubitemid 351227429)
49. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juilliere Y. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49:1733-1739. (Pubitemid 46589928)
50. Stevenson LW. Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 2006;113:1020-1027; discussion 1033.
51. Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM, Myerberg RJ. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 1991;90:353-359.
52. Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 1993;22:968-974. (Pubitemid 23285744)
53. Drazner MH, Hellkamp AS, Leier CV, Shah MR, Miller LW, Russell SD, Young JB, Califf RM, Nohria A. Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure: the ESCAPE Trial. Circ Heart Fail 2008;1:170-177.
54. Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008;29:816-824. (Pubitemid 351431028)
55. Beck da Silva L, Mielniczuk L, Laberge M, Anselm A, Fraser M, Williams K, Haddad H. Persistent orthopnea and the prognosis of patients in the heart failure clinic. Congest Heart Fail 2004;10:177-180.
56. Shah MR, Hasselblad V, Gheorghiade M, Adams KF Jr, Swedberg K, Califf RM, O'Connor CM. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2001;88:987-993. (Pubitemid 33042609)
57. Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant 1999;18:1126-1132.
58. Vinayak AG, Levitt J, Gehlbach B, Pohlman AS, Hall JB, Kress JP. Usefulness of the external jugular vein examination in detecting abnormal central venous pressure in critically ill patients. Arch Intern Med 2006;166:2132-2137. (Pubitemid 44631402)
59. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009;53:557-573.
60. Leier CV, Young JB, Levine TB, Pina I, Armstrong PW, Fowler MB, Warner-Stevenson L, Cohn JN, O'Connell JB, Bristow MR, Nicklas JM, Johnstone DE, Howlett J, Ventura HO, Giles TD, Greenberg BH, Chatterjee K, Bourge RC, Yancy CW, Gottleib SS. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail 2001;7:297-308.
61. Sochowski RA, Dubbin JD, Naqvi SZ. Clinical and hemodynamic assessment of the hepatojugular reflux. Am J Cardiol 1990;66:1002-1006. (Pubitemid 20360596)
62. Wiese J. The abdominojugular reflux sign. Am J Med 2000;109:59-61. (Pubitemid 30608738)
63. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-689. (Pubitemid 30167025)
64. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210. (Pubitemid 30451778)
65. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002;8:136-141. (Pubitemid 34857278)
66. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI. Correlates and impact on outcomes of worsening renal function in patients. or =65 years of age with heart failure. Am J Cardiol 2000;85:1110-1113. (Pubitemid 30214258)
67. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003;9:13-25. (Pubitemid 36356697)
68. Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006;27:1216-1222.
69. Schrier RW. Blood urea nitrogen and serum cratinine - not married in heart failure. Circ Heart Fail 2008;1:2-5.
70. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 2004;116:466-473. (Pubitemid 38388616)
71. Shenkman HJ, Zareba W, Bisognano JD. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure. Am J Cardiol 2007;99:1143-1145. (Pubitemid 46560453)
72. Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'Connor C, Adams KF, Orlandi C, Gheorghiade M. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail 2007;13:360-364. (Pubitemid 46977793)
73. Klein L, Massie BM, Leimberger JD, O'Connor CM, Pina IL, Adams KF, Califf RM, Gheorghiade M. Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predicts Postdischarge Survival. Circ Heart Fail 2008;1:25-33.
74. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007;49:1943-1950. (Pubitemid 46694287)
75. Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008;10:824-839.
76. Baggish AL, van Kimmenade RR, Januzzi JL Jr. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 2008;101:43-48.
77. Wu AH, Smith A, Apple FS. Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure. Am J Cardiol 2004;93:1562-1563. (Pubitemid 38749224)
78. McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA 1999;281:1022-1029.
79. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 1992;85:510-517.
80. Weilenmann D, Rickli H, Follath F, Kiowski W, Brunner-La Rocca HP. Noninvasive evaluation of pulmonary capillary wedge pressure by BP response to the Valsalva maneuver. Chest 2002;122:140-145. (Pubitemid 34754153)
81. Greenfield JC Jr, Cox RL, Hernandez RR, Thomas C, Schoonmaker FW. Pressureflow studies in man during the Valsalva maneuver with observations on the mechanical properties of the ascending aorta. Circulation 1967;35:653-661.
82. Felker GM, Cuculich PS, Gheorghiade M. The Valsalva maneuver: a bedside 'biomarker' for heart failure. Am J Med 2006;119:117-122. (Pubitemid 43151474)
83. Little WC, Barr WK, Crawford MH. Altered effect of the Valsalva maneuver on left ventricular volume in patients with cardiomyopathy. Circulation 1985;71:227-233. (Pubitemid 15157082)
84. Knowles JH, Gorlin R, Storey CF. Clinical test for pulmonary congestion with use of the Valsalva maneuver. JAMA 1956;160:44-48.
85. Zema MJ, Restivo B, Sos T, Sniderman KW, Kline S. Left ventricular dysfunction-bedside Valsalva manoeuvre. Br Heart J 1980;44:560-569. (Pubitemid 11217141)
86. Zema MJ, Caccavano M, Kligfield P. Detection of left ventricular dysfunction in ambulatory subjects with the bedside Valsalva maneuver. Am J Med 1983;75:241-248. (Pubitemid 13030864)
87. Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, Hanson K, Li SY, deFilippi CR. Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function. Eur J Heart Fail 2009;11:659-667.
88. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66:493-496. (Pubitemid 20259386)
89. Goonewardena SN, Gemignana A, Ronan A, Vasaiwala S, Blair J, Brennan JM, Shah DP, Spencer KT. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. J Am Coll Cardiol Cardiovasc Imaging 2008;1:595-601.
90. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-1533. (Pubitemid 27486472)
91. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue Doppler imaging. Circulation 1998;98:1644-1650. (Pubitemid 28500387)
92. Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, Nagueh SF. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 2004;109:2432-2439. (Pubitemid 38679564)
93. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005;45:1223-1226. (Pubitemid 40523141)
94. Nguyen VT, Ho JE, Ho CY, Givertz MM, Stevenson LW. Handheld echocardiography offers rapid assessment of clinical volume status. Am Heart J 2008;156:537-542.
95. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007;49:1903-1914. (Pubitemid 46711162)
96. Solomon SD, Stevenson LW. Recalibrating the barometer: is it time to take a critical look at noninvasive approaches to measuring filling pressures? Circulation 2009;119:13-15.
97. Jambrik Z, Monti S, Coppola V, Agricola E, Mottola G, Miniati M, Picano E. Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol 2004;93:1265-1270. (Pubitemid 38595681)
98. Nohria A, Mielniczuk LM, Stevenson LW. Evaluation and monitoring of patients with acute heart failure syndromes. Am J Cardiol 2005;96:32G-40G. (Pubitemid 41338072)
99. Fonarow GC. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003;4(Suppl. 7): S21-S30. (Pubitemid 37526952)
100. Brennan JM, Blair JE, Goonewardena S, Ronan A, Shah D, Vasaiwala S, Brooks E, Levy A, Kirkpatrick JN, Spencer KT. A comparison by medicine residents of physical examination versus hand-carried ultrasound for estimation of right atrial pressure. Am J Cardiol 2007;99:1614-1616. (Pubitemid 46770646)
101. Yancy C, Abraham WT. Noninvasive hemodynamic monitoring in heart failure: utilization of impedance cardiography. Congest Heart Fail 2003;9:241-250.
102. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 2006;47:2245-2252. (Pubitemid 43795052)
103. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, van Veldhuisen DJ. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail 2008;10:907-916.
104. Prentice TC, Berlin NI, Hyde GM, Parsons RJ, Lawrence JH, Port S. Total red cell volume, plasma volume, and sodium space in congestive heart failure. J Clin Invest 1951;30:1471-1482.
105. Reilly WA, French RM, Lau FY, Scott KG, White WE. Whole blood volume determined by radiochromium-tagged red cells; comparative studies on normal and congestive heart failure patients. Circulation 1954;9:571-580.
106. Gunton RW, Paul W. Blood volume in congestive heart failure. J Clin Invest 1955;34:879-886.
107. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989;80:299-305. (Pubitemid 19195738)
108. James KB, Troughton RW, Feldschuh J, Soltis D, Thomas D, Fouad-Tarazi F. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study. Am Heart J 2005;150:984.
109. Katz SD. Blood volume assessment in the diagnosis and treatment of chronic heart failure. Am J Med Sci 2007;334:47-52. (Pubitemid 47067445)
110. Cody RJ. The need for a sodium retention score in clinical trials of heart failure. Clin Pharmacol Ther 1993;54:7-10. (Pubitemid 23227509)